Mechanisms of Traditional Chinese Medicine Enema Therapy in the Treatment of Atopic Dermatitis: A Gut–Skin Axis Perspective
Main Article Content
Keywords
atopic dermatitis, gut–skin axis, traditional Chinese medicine enema, gut microbiota
Abstract
Atopic dermatitis (AD) is closely associated with dysbiosis of the gut microbiota. Based on the “gut–skin axis” theory, this review comprehensively examines the mechanisms underlying traditional Chinese medicine (TCM) enema therapy in AD. Gut dysbiosis, intestinal barrier disruption, and depletion of microbial metabolites can activate systemic immunity, driving Th2/Th17 polarization and elevated IgE levels. Integrated with TCM principles of “intestinal damp–heat” and “spleen deficiency with dampness excess,” TCM enema administration achieves high local rectal concentrations through rectal delivery, exerting therapeutic effects via multidimensional mechanisms: remodeling the gut microbiota, repairing the intestinal barrier (upregulating ZO-1/Occludin), inducing regulatory T cell (Treg) differentiation, suppressing systemic inflammation through TLR4/NF-κB and vagus nerve pathways, and modulating the neuro–endocrine–immune network to alleviate the itch–anxiety cycle. Compared with the limitations and adverse effects of conventional Western therapies, TCM enema represents a “treating the gut to modulate the skin” strategy that demonstrates unique advantages in moderate-to-severe and refractory AD, offering a novel integrated approach for the prevention and management of AD.
References
- [1]Liu L, Xian-Ming P, Li W. Pathogenesis of atopic dermatitis and its regulation by traditional Chinese medicine. Lishizhen Medicine and Materia Medica Research. 2022;33(6):1418–1420.
- [2]Zhang Z, Zhang H, Guan J, et al. Gut–brain–skin axis-based exploration of the pathogenesis of atopic dermatitis and research progress in traditional Chinese medicine treatment. Journal of Shenyang Pharmaceutical University. 2024;41(3).
- [3]Li Y, Feng X, Chen R, et al. Research progress in traditional Chinese medicine treatment of atopic dermatitis based on the gut–brain–skin axis. International Journal of Traditional Chinese Medicine. 2024;(3).
- [4]Wu M, Zhang F, Wang J. Traditional Chinese medicine retention enema for allergic skin diseases based on the “skin–lung–intestine” axis theory. Jilin Journal of Traditional Chinese Medicine. 2025;45(1):72–75.
- [5]Ma X, Yang S, Yuan R. Research progress on traditional Chinese medicine regulating gut microbiota for treatment of atopic dermatitis. China Medical Herald. 2022;(29).
- [6]Lan X, Zhang X, Dou J. Research progress on the influence of the “gut–skin” axis on skin diseases and the interventional effects of traditional Chinese medicine. Central South Pharmacy. 2025;23(12).
- [7]Liu M, Chen A, Zeng J, et al. Treatment of pediatric atopic dermatitis from the perspective of multi-target network regulation. Acta Chinese Medicine. 2025;(5).
- [8]Zhang N, An Y, Yang S. Mechanisms of gut microbiota intervention in atopic dermatitis and progress in traditional Chinese medicine treatment based on the “gut–skin” axis. Chinese Herbal Medicines. 2025;(4).
- [9]Diez-Madueno K, de la Cueva Dobao P, et al. Compositional and functional profile of gut microbiota in a cohort of adult Spanish patients with atopic dermatitis using metagenomics: a cross-sectional study. Dermatitis. 2025;36(4). DOI:10.1089/derm.2024.0536.
- [10]Hu Y, Li Z. Analysis of differences in gut microbiota and inflammatory factor levels between children with atopic dermatitis and healthy children. Journal of Modern Medicine (China). 2026;36(2).
- [11]Wang X, Wu L, Zhang G. Exploring the pathogenesis of inflammatory skin diseases from the perspective of gut microbiota dysbiosis. Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine. 2021;20(5):522–525.
- [12]Holge IM, Kaesler S, Hils M, et al. Unraveling the kinetics and cellular contributions in type 2 immune responses in atopic dermatitis. Journal of Investigative Dermatology. 2021;141(10). DOI:10.1016/j.jid.2021.08.018.
- [13]Yang J, Zhang J, Chi X. Distribution of helper and regulatory T lymphocyte subsets in children with atopic dermatitis of varying severity and their relationship with clinical features. Chinese Journal of Immunology. 2026;42(2).
- [14]Zhang J, Zheng X, Cao X. Correlation between atopic dermatitis and the gut microbiome. China Journal of Leprosy and Skin Diseases. 2020;36(2):122–125.
- [15]Suratannon N, Chatchatee P, Nakpaichit M, et al. Gut dysbiosis highlights the role of methionine, serotonin, and PPAR-γ pathways in atopic dermatitis and food allergy phenotypes. Journal of Allergy and Clinical Immunology. 2025;155(2). DOI:10.1016/j.jaci.2024.12.915.
- [16]Wang Z, Men Y, Ju Y, et al. Research progress on atopic dermatitis. Chinese Journal of Birth Health and Heredity. 2021;(3):292–296.
- [17]Yang G, Seok JK, Kang HC, et al. Skin barrier abnormalities and immune dysfunction in atopic dermatitis. International Journal of Molecular Sciences. 2020;21(8). DOI:10.3390/ijms21082867.
- [18]Wang W, Li Y, Zeng J, et al. Research progress on the prevention and treatment of atopic dermatitis by probiotics and their mechanisms. Acta Microbiologica Sinica. 2024;64(5):1378–1391.
- [19]Li X, Wang F, Xu S, et al. Research progress on probiotics for prevention and treatment of atopic dermatitis. Microbiology China. 2022;(1):283–291.
- [20]Zhang X, Huang X, Zheng P, et al. Changes in oral, skin, and gut microbiota in children with atopic dermatitis: a case-control study. Frontiers in Microbiology. 2024;15:1442126. DOI:10.3389/fmicb.2024.1442126.
- [21]Kim HB, Alexander H, Um JY, et al. Skin microbiome dynamics in atopic dermatitis: understanding host–microbiome interactions. Allergy, Asthma & Immunology Research. 2025;17(2):165–180. DOI:10.4168/aair.2025.17.2.165.
- [22]Blicharz L, Rudnicka L, Czuwara J, et al. The influence of microbiome dysbiosis and bacterial biofilms on epidermal barrier function in atopic dermatitis—an update. International Journal of Molecular Sciences. 2021;22(16). DOI:10.3390/ijms22168403.
- [23]Boggio CMT, Veronese F, Armari M, et al. Skin microbiota in atopic dermatitis: victim or executioner? Clinical Microbiology Reviews. 2025;38(3):e0027724. DOI:10.1128/cmr.00277-24.
- [24]Moniaga CS, Tominaga M, Takamori K. An altered skin and gut microbiota are involved in the modulation of itch in atopic dermatitis. Cells. 2022;11(23). DOI:10.3390/cells11233930.
- [25]Fang Z, Li L, Zhang H, et al. Gut microbiota, probiotics, and their interactions in prevention and treatment of atopic dermatitis: a review. Frontiers in Immunology. 2021;12:720393. DOI:10.3389/fimmu.2021.720393.
- [26]Chen Y, Wang Y, Song S, et al. Research progress on the gut–skin axis in three inflammatory skin diseases. Chinese Pharmacological Bulletin. 2022;(7).
- [27]Zhao Y, Yu C, Zhang J, et al. The gut–skin axis: emerging insights in understanding and treating skin diseases through gut microbiome modulation (Review). International Journal of Molecular Medicine. 2025;56(6). DOI:10.3892/ijmm.2025.5651.
- [28]Haidar L, Bănărescu CF, Uța C, et al. Beyond the skin: exploring the gut–skin axis in chronic spontaneous urticaria and other inflammatory skin diseases. Biomedicines. 2025;13(8). DOI:10.3390/biomedicines13082014.
- [29]Kothari R, Dong X. The neuroimmune axis: integrating two systems to decipher itch. Neuron. 2026. DOI:10.1016/j.neuron.2025.12.039.
- [30]Sun J, Gao M, Yao X, et al. Research progress on pruritus mechanisms in atopic dermatitis. China Journal of Leprosy and Skin Diseases. 2025;41(10):765–770.
- [31]Steinhoff M, Ahmad F, Pandey A, et al. Neuroimmune communication regulating pruritus in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2022;149(6):1875–1898. DOI:10.1016/j.jaci.2022.03.010.
- [32]Peng Z, Hui J, Xiao Y, et al. Mechanisms of acupuncture treatment for acne based on the “gut–brain–skin” axis theory. Clinical Journal of Acupuncture and Moxibustion. 2025;41(10):91–95.
- [33]Zhang X, Wang X, Yang Z, et al. The “skin–gut” axis and atopic dermatitis from a microbiological perspective. Microbiology China. 2022;(11).
- [34]Park DH, Kim JW, Park HJ, et al. Comparative analysis of the microbiome across the gut–skin axis in atopic dermatitis. International Journal of Molecular Sciences. 2021;22(8). DOI:10.3390/ijms22084228.
- [35]Wang Y, Mei D, Guo L, et al. Probiotics ameliorate skin diseases via the gut–skin axis. Chemistry of Life. 2021;(6):1288–1294.
- [36]Gong Y, Kou M, Shen Y, et al. Analysis of herbal formula patterns in traditional Chinese medicine enema for ulcerative colitis based on data mining. China Medical Herald. 2021;18(16):109–112.
- [37]Xu Y, Zhao C, Luo L, et al. Exploration of the microscopic mechanisms and theoretical pharmacology of ulcerative colitis based on the “clarity–turbidity interaction” theory. Chinese Journal of Experimental Traditional Medical Formulae. 2026;(1).
- [38]Yang Q, Zhang X, Guo H, et al. Biological connotation of the “liver depression and spleen deficiency” pathogenesis in slow-transit constipation based on the brain–gut–microbiota axis. Modern Journal of Integrated Traditional Chinese and Western Medicine. 2024;33(23).
- [39]Xiao Q, Liu J, Shi M, et al. Mechanisms of Bu-Shen-Yi-Chang pills in reshaping Tfh cell homeostasis for ulcerative colitis with spleen deficiency and dampness accumulation. Traditional Chinese Drug Research and Clinical Pharmacology. 2026;37(1). DOI:10.19378/j.issn.1003-9783.2026.01.010.
- [40]Wang X, Yang D, Guo L. “Turbidity-eliminating and detoxifying” traditional Chinese medicine enema for residual SARS-CoV-2 in stool. Journal of Zhejiang Chinese Medical University. 2020;44(8):734–737.
- [41]Sun S. Clinical study of Weng-She decoction enema for large-intestine damp–heat type ulcerative colitis. Shandong Journal of Traditional Chinese Medicine. 2021;40(5):482–485,490.
- [42]Yang X, Wang Y, Jiao H, et al. Efficacy of oral traditional Chinese medicine combined with enema for steroid-dependent ulcerative colitis and its effects on gut microbiota and inflammatory factors. Modern Journal of Integrated Traditional Chinese and Western Medicine. 2025;(9).
- [43]Yang X, Peng S, Wang P, et al. Multi-omics analysis reveals classic decoction alleviates ulcerative colitis by modulating tryptophan metabolism, gut microbiota homeostasis, and mitochondrial Bax/Bcl-2 pathways. Journal of Pharmaceutical and Biomedical Analysis. 2025;264:116972. DOI:10.1016/j.jpba.2025.116972.
- [44]Zhang L, Li W, Yu Q. Clinical observation of a self-designed ulcerative-colitis enema formula combined with mesalazine for ulcerative colitis (spleen deficiency/damp accumulation type). China Pharmaceuticals. 2025;34(14):97–101.
- [45]Wan M, Liu W, Liu Y, et al. Multiomics-based investigation on the mechanism of Dachengqi decoction in improving constipation through the microbiota–gut–brain axis. Bioorganic Chemistry. 2025;164:108895. DOI:10.1016/j.bioorg.2025.108895.
- [46]Wanli J, Xingyue S, Xinning L, et al. Banxia Xiexin Decoction modulates short-chain fatty acid metabolism and mitigates ulcerative colitis by reshaping the intestinal microbiota. Journal of Pharmaceutical and Biomedical Analysis. 2026;271:117332. DOI:10.1016/j.jpba.2025.117332.
- [47]Zhang SY, Qian Z, Mao X, et al. Banxia Xiexin Decoction restores gastrointestinal function, reduces inflammation, and normalizes microbiota in functional dyspepsia model rats. Gastroenterology. 2025;169(1). DOI:10.1016/S0016-5085(25)02887-2.
- [48]Zhang L, Chen N, Liao Y, et al. Efficacy and action mechanisms of compound Shen Chan decoction on experimental models of atopic dermatitis. International Immunopharmacology. 2024;137:112479. DOI:10.1016/j.intimp.2024.112479.
- [49]Zhou Y, Zhang D, Cheng H, et al. Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota. Frontiers in Cellular and Infection Microbiology. 2024;14:1389925. DOI:10.3389/fcimb.2024.1389925.
- [50]Che Q, Luo T, Shi J, et al. Mechanisms by which traditional Chinese medicines influence the intestinal flora and intestinal barrier. Frontiers in Cellular and Infection Microbiology. 2022;12:863779. DOI:10.3389/fcimb.2022.863779.
- [51]Ma X, Huang C, Cheng Z, et al. Clinical and experimental study of Gu-Ben-Hua-Shi formula in the treatment of atopic dermatitis. Chinese Journal of Integrated Traditional and Western Medicine. 2025;45(5).
- [52]Yang J, Guo J, Tang P, et al. Insights from traditional Chinese medicine for restoring skin barrier functions. Pharmaceuticals (Basel). 2024;17(9). DOI:10.3390/ph17091176.
- [53]Wu J, Tai Z, Zhu C, et al. Yin-Hua Li-Shi Decoction alleviated atopic dermatitis through regulating Th cells balance and restoring epithelial barrier. Journal of Inflammation Research. 2025;18:14569–14587. DOI:10.2147/JIR.S531656.
- [54]Tang X, Huang Y, Zhu Y, et al. Immune dysregulation in ulcerative colitis: pathogenic mechanisms and therapeutic strategies of traditional Chinese medicine. Frontiers in Cell and Developmental Biology. 2025;13:1610435. DOI:10.3389/fcell.2025.1610435.
- [55]Zhou Q, Guo W, Deng Y. Research progress on active traditional Chinese medicine compounds intervening in abnormal transcriptional regulation in atopic dermatitis. Bulletin of Dermatology. 2024;41(3).
- [56]Yang S, Liu J, Deng S, et al. Mechanism of Wu-Mei-Wan in inhibiting epidermal inflammation-mediated Th2-type inflammatory response for treatment of atopic dermatitis. Chinese Journal of New Drugs. 2025;34(14).
- [57]Zhang L, Lin H, Chen N, et al. Selected traditional Chinese herbal medicines for the treatment of atopic dermatitis—research progress on the effect and mechanism of actions. Frontiers in Pharmacology. 2025;16:1553251. DOI:10.3389/fphar.2025.1553251.
- [58]Hu M, Liu A, Ma M, et al. Research progress on traditional Chinese medicine regulating the NLRP3 inflammasome for treatment of atopic dermatitis. Chinese Journal of Experimental Traditional Medical Formulae. 2026;32(4). DOI:10.13422/j.cnki.syfjx.20250937.
- [59]Li L, He J, Li M, et al. Mechanism of Huang-Lian ointment in treating atopic dermatitis via inhibition of IL-18 and IL-33. Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine. 2025;24(4):335–337.
- [60]Li D, Yu Y, Zhu Z, et al. Analysis of treating atopic dermatitis from the heart based on the theory that “the heart governs the exterior”. Global Traditional Chinese Medicine. 2023.
- [61]Zhang R, Zhang H, Shao S, et al. Compound traditional Chinese medicine dermatitis ointment ameliorates inflammatory responses and dysregulation of itch-related molecules in atopic dermatitis. Chinese Medicine. 2022;17(1):3. DOI:10.1186/s13020-021-00555-7.
- [62]Qu W, Du W. Research progress on traditional Chinese medicine prevention and treatment of atopic dermatitis. Sichuan Journal of Traditional Chinese Medicine. 2025;43(7).
- [63]Srivastava K, Yang N, Uzun S, et al. Effect of traditional Chinese medicine (TCM) in moderate-to-severe eczema in clinic and animal model: beyond corticosteroids. Journal of Allergy and Clinical Immunology. 2020;145(2). DOI:10.1016/j.jaci.2019.12.291.
- [64]Siegels D, Heratizadeh A, Abraham S, et al. Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. Allergy. 2020;76(4):1053–1076. DOI:10.1111/all.14631.
- [65]Drucker AM, Morra DE, Prieto-Merino D, et al. Systemic immunomodulatory treatments for atopic dermatitis: update of a living systematic review and network meta-analysis. JAMA Dermatology. 2022;158(5):523–532. DOI:10.1001/jamadermatol.2022.0455.
- [66]Barbarot S, Wollenberg A, Silverberg JI, et al. Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials. Journal of Dermatological Treatment. 2020;33(1):266–277. DOI:10.1080/09546634.2020.1750550.
- [67]Agache I, Akdis CA, Akdis M, et al. EAACI Biologicals Guidelines—dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy. 2020;76(4):988–1009. DOI:10.1111/all.14690.
- [68]Li Y, Lu J, Chen R, et al. The efficacy and safety of dupilumab for the treatment of atopic dermatitis among Chinese patients in clinical practice: a single-center retrospective study. Dermatologic Therapy. 2022;35(5):e15385. DOI:10.1111/dth.15385.
- [69]Vilsbøll AW, Anderson P, Piercy J, et al. Extent and impact of inadequate disease control in US adults with a history of moderate to severe atopic dermatitis following introduction of new treatments. Dermatology and Therapy. 2021;11(2):475–486. DOI:10.1007/s13555-021-00488-x.
- [70]Gu Y, Qian H. Research progress on systemic pharmacotherapy for pediatric atopic dermatitis. Chinese Journal of Practical Pediatrics. 2021;36(9):655–660.
- [71]Nusbaum KB, Fleischer S, Fleischer AB. Efficacy of biologics and oral small molecules for atopic dermatitis: a systematic review and meta-analysis. Journal of Dermatological Treatment. 2021;33(5):2534–2544. DOI:10.1080/09546634.2021.1986204.
- [72]Yang L, Li D, Sun S, et al. Dupilumab therapy improves gut microbiome dysbiosis and tryptophan metabolism in Chinese patients with atopic dermatitis. International Immunopharmacology. 2024;131:111867. DOI:10.1016/j.intimp.2024.111867.
- [73]Editorial board. Feature on clinical and basic research of traditional Chinese medicine for atopic dermatitis: editorial introduction. Beijing Journal of Traditional Chinese Medicine. 2025;44(11).
- [74]Drucker AM, Ellis AG, Bohdanowicz M, et al. Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis. JAMA Dermatology. 2020;156(6):659–667. DOI:10.1001/jamadermatol.2020.0796.
- [75]Cai W, Wang D, Yang X, et al. Efficacy of Qing-Re-Qu-Shi formula in treating atopic dermatitis with damp–heat immersion syndrome and its effect on Th17/Treg immune homeostasis. Journal of Guangzhou University of Traditional Chinese Medicine. 2026;43(3). DOI:10.13359/j.cnki.gzxbtcm.2026.03.014.
- [76]Ma Y, Zhang Y, Ya X, et al. Effect of modified Jian-Pi-Chu-Shi decoction combined with dupilumab on skin barrier function in adult patients with moderate-to-severe atopic dermatitis. Journal of Clinical and Experimental Medicine. 2025;24(13):1439–1443.
- [77]Zhang Z, Wu Y, Hao G. Clinical efficacy of Shen-Ling-Bai-Zhu powder combined with dupilumab in patients with moderate-to-severe atopic dermatitis and its effects on Th17/Treg, Th1/Th2, and related inflammatory factors. World Journal of Integrated Traditional and Western Medicine. 2025;(4).
- [78]Gong K, Ji X, Wu S, et al. Research progress on traditional Chinese medicine regulating related signaling pathways for treatment of atopic dermatitis. Chinese Journal of Immunology. 2025;41(12).
- [79]Shan X, Zhao W, Deng H, et al. Research progress on traditional Chinese medicine regulating the JAK-STAT pathway for treatment of atopic dermatitis. Modern Chinese Medicine. 2025;(7).
- [80]Dong X, Zhang Y, An Y, et al. Research progress on traditional Chinese medicine regulating the MAPK signaling pathway for treatment of atopic dermatitis. Central South Pharmacy. 2025;23(10):2983–2989.
- [81]Cai X, Sun X, Liu L, et al. Efficacy and safety of Chinese herbal medicine for atopic dermatitis: evidence from eight high-quality randomized placebo-controlled trials. Frontiers in Pharmacology. 2022;13:927304. DOI:10.3389/fphar.2022.927304.
- [82]Xu J, Ying C. Current status and prospects of traditional Chinese medicine treatment of atopic dermatitis. Beijing Journal of Traditional Chinese Medicine. 2025;44(11). DOI:10.16025/j.1674-1307.2025.11.001.
- [83]Coyle ME, Zhang AL, Xue CC, et al. Chinese herbal medicine for atopic dermatitis: a systematic review of registered randomised controlled trials. Dermatologic Therapy. 2025;2025(1). DOI:10.1155/dth/9920370.
- [84]Yang Y, Chi H, Wang Q, et al. Therapeutic effect of the Long-Mu-Tang herbal compound on atopic dermatitis rats via regulation of the JAK2/STAT3 signaling pathway. Hebei Journal of Traditional Chinese Medicine. 2025;(7).
- [85]Zeng SH, Jiang XY, Lin DR, et al. Mechanisms and therapeutic potential of traditional Chinese medicine for inflammatory bowel disease. World Journal of Gastroenterology. 2026;32(10):115821. DOI:10.3748/wjg.v32.i10.115821.
